chr18-45625698-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007163.4(SLC14A2):āc.166A>Gā(p.Asn56Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,553,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007163.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC14A2 | NM_007163.4 | c.166A>G | p.Asn56Asp | missense_variant | 3/20 | ENST00000255226.11 | |
LOC105372093 | XR_935423.3 | n.1207+11125T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC14A2 | ENST00000255226.11 | c.166A>G | p.Asn56Asp | missense_variant | 3/20 | 1 | NM_007163.4 | P1 | |
SLC14A2 | ENST00000586448.5 | c.166A>G | p.Asn56Asp | missense_variant | 4/21 | 2 | P1 | ||
SLC14A2 | ENST00000323329.3 | c.166A>G | p.Asn56Asp | missense_variant, NMD_transcript_variant | 3/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 4AN: 200980Hom.: 0 AF XY: 0.0000182 AC XY: 2AN XY: 109894
GnomAD4 exome AF: 0.00000571 AC: 8AN: 1400694Hom.: 0 Cov.: 31 AF XY: 0.00000432 AC XY: 3AN XY: 694344
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2023 | The c.166A>G (p.N56D) alteration is located in exon 3 (coding exon 2) of the SLC14A2 gene. This alteration results from a A to G substitution at nucleotide position 166, causing the asparagine (N) at amino acid position 56 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at